| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms
|
Segalés, J.
|
|
2009
|
27 |
52 |
p. 7313-7321
9 p.
|
artikel
|
| 2 |
Analysis of biomarkers after intramuscular injection of Vaxfectin®-formulated hCMV gB plasmid DNA
|
Vilalta, Adrián
|
|
2009
|
27 |
52 |
p. 7409-7417
9 p.
|
artikel
|
| 3 |
A novel virus-like particle based on hepatitis B core antigen and substrate-binding domain of bacterial molecular chaperone DnaK
|
Wang, Xue Jun
|
|
2009
|
27 |
52 |
p. 7377-7384
8 p.
|
artikel
|
| 4 |
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® +CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults
|
Sagara, Issaka
|
|
2009
|
27 |
52 |
p. 7292-7298
7 p.
|
artikel
|
| 5 |
A Valedictory Editorial
|
Spier, Ray
|
|
2009
|
27 |
52 |
p. 7468-7470
3 p.
|
artikel
|
| 6 |
Brainstem encephalitis following influenza vaccination: Favorable response to steroid treatment
|
Türkoğlu, Recai
|
|
2009
|
27 |
52 |
p. 7253-7256
4 p.
|
artikel
|
| 7 |
Conclusions on (cost-)effectiveness of pertussis booster vaccination strategies highly dependent on selections made in evidence review
|
Postma, Maarten J.
|
|
2009
|
27 |
52 |
p. 7242-7243
2 p.
|
artikel
|
| 8 |
Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1)
|
Yang, Shi-gui
|
|
2009
|
27 |
52 |
p. 7451-7458
8 p.
|
artikel
|
| 9 |
Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: Protection against Bordetella pertussis challenge in neonates
|
Nascimento, Ivan P.
|
|
2009
|
27 |
52 |
p. 7346-7351
6 p.
|
artikel
|
| 10 |
Corrigendum to “Immunogenicity, reactogenicity and persistence of meningococcal A, C,W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years” [Vaccine 27 (2009) 161–168]
|
Østergaard, Lars
|
|
2009
|
27 |
52 |
p. 7467-
1 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2009
|
27 |
52 |
p. CO2-
1 p.
|
artikel
|
| 12 |
Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease
|
Hausdorff, W.P.
|
|
2009
|
27 |
52 |
p. 7257-7269
13 p.
|
artikel
|
| 13 |
Evaluation of Echinococcus multilocularis tetraspanins as vaccine candidates against primary alveolar echinococcosis
|
Dang, Zhisheng
|
|
2009
|
27 |
52 |
p. 7339-7345
7 p.
|
artikel
|
| 14 |
Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice
|
Aguado-Martínez, Adriana
|
|
2009
|
27 |
52 |
p. 7331-7338
8 p.
|
artikel
|
| 15 |
Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine
|
Lin, Cheng-Tao
|
|
2009
|
27 |
52 |
p. 7352-7358
7 p.
|
artikel
|
| 16 |
Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults
|
Chu, Daniel Wai-Sing
|
|
2009
|
27 |
52 |
p. 7428-7435
8 p.
|
artikel
|
| 17 |
Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron
|
Naskalska, A.
|
|
2009
|
27 |
52 |
p. 7385-7393
9 p.
|
artikel
|
| 18 |
Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study
|
Arnou, Robert
|
|
2009
|
27 |
52 |
p. 7304-7312
9 p.
|
artikel
|
| 19 |
Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice
|
Madhun, Abdullah S.
|
|
2009
|
27 |
52 |
p. 7367-7376
10 p.
|
artikel
|
| 20 |
Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: Comparison of formulations and administration routes of vaccines
|
Kashima, Yoshitaka
|
|
2009
|
27 |
52 |
p. 7402-7408
7 p.
|
artikel
|
| 21 |
Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine
|
Hammitt, Laura L.
|
|
2009
|
27 |
52 |
p. 7359-7366
8 p.
|
artikel
|
| 22 |
Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain
|
Suter, Mark
|
|
2009
|
27 |
52 |
p. 7442-7450
9 p.
|
artikel
|
| 23 |
Overview of the disease burden of invasive pneumococcal disease in Asia
|
Bravo, L.C.
|
|
2009
|
27 |
52 |
p. 7282-7291
10 p.
|
artikel
|
| 24 |
Priorities in research and development of vaccines against Plasmodium vivax malaria
|
Brown, Graham V.
|
|
2009
|
27 |
52 |
p. 7228-7235
8 p.
|
artikel
|
| 25 |
Protection against anthrax and plague by a combined vaccine in mice and rabbits
|
Ren, Jun
|
|
2009
|
27 |
52 |
p. 7436-7441
6 p.
|
artikel
|
| 26 |
Protective efficacy of bacterial membranes containing surface-exposed BM95 antigenic peptides for the control of cattle tick infestations
|
Canales, Mario
|
|
2009
|
27 |
52 |
p. 7244-7248
5 p.
|
artikel
|
| 27 |
Protective efficacy of two new anti-caries DNA vaccines
|
Sun, Jinghua
|
|
2009
|
27 |
52 |
p. 7459-7466
8 p.
|
artikel
|
| 28 |
Rapid responses to: “Letter to the Editor” by L. Garattini and G. Casadei [Vaccine 27 (38) (20 August 2009) 5171]
|
Mennini, Francesco Saverio
|
|
2009
|
27 |
52 |
p. 7238-7239
2 p.
|
artikel
|
| 29 |
Regulatory oversight of clinical trials in Africa: Progress over the past 5 years
|
Maïga, Diadié
|
|
2009
|
27 |
52 |
p. 7249-7252
4 p.
|
artikel
|
| 30 |
Remission of chronic urticaria in the course of house dust mite immunotherapy—Mere coincidence or something more to it?
|
Kasperska-Zajac, Alicja
|
|
2009
|
27 |
52 |
p. 7240-7241
2 p.
|
artikel
|
| 31 |
Report of the ‘European Expert Meeting on Rotavirus Vaccination’, Tampere, Finland, 19–20 May 2009
|
Vesikari, Timo
|
|
2009
|
27 |
52 |
p. 7222-7227
6 p.
|
artikel
|
| 32 |
Resistance to mycobacterial infection: A pattern of early immune responses leads to a better control of pulmonary infection in C57BL/6 compared with BALB/c mice
|
Arko-Mensah, John
|
|
2009
|
27 |
52 |
p. 7418-7427
10 p.
|
artikel
|
| 33 |
Risk of immune hemolytic anemia in children following immunization
|
Naleway, Allison L.
|
|
2009
|
27 |
52 |
p. 7394-7397
4 p.
|
artikel
|
| 34 |
Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far
|
Agorastos, Theodoros
|
|
2009
|
27 |
52 |
p. 7270-7281
12 p.
|
artikel
|
| 35 |
Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep
|
Oura, C.A.L.
|
|
2009
|
27 |
52 |
p. 7326-7330
5 p.
|
artikel
|
| 36 |
Small fiber neuropathy following vaccination for rabies, varicella or Lyme disease
|
Souayah, Nizar
|
|
2009
|
27 |
52 |
p. 7322-7325
4 p.
|
artikel
|
| 37 |
The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali
|
Traore, Boubacar
|
|
2009
|
27 |
52 |
p. 7299-7303
5 p.
|
artikel
|
| 38 |
Tracking epitope-specific antiviral CD4+ T cell responses to a live attenuated vaccine reveals ongoing functional responses
|
Jones, L.
|
|
2009
|
27 |
52 |
p. 7398-7401
4 p.
|
artikel
|
| 39 |
WHO position on HPV vaccines
|
|
|
2009
|
27 |
52 |
p. 7236-7237
2 p.
|
artikel
|
| 40 |
WHO position on measles vaccines
|
|
|
2009
|
27 |
52 |
p. 7219-7221
3 p.
|
artikel
|
Tijdschrift beschrijving